Twenty female volunteers (age range, 18-30) participated in this double-blind, crossover and 12 within-subject study. All participants gave informed consent and the protocol of the study has 13 been approved by the medical ethics committee (METC) of the University Medical Centre 14 Utrecht, The Netherlands. Participants received a single dose of 0.5 mg sublingual 15 testosterone in one session and placebo in the other session, with a 7-day latency between 16 sessions. They received payment consisting of €10 as a fixed fee plus earnings depending on 17 their performance in the poker game. Subjects had no (history of) psychiatric disorders or 18 neurological or endocrine abnormalities, did not smoke, and used no medication other than 19 contraceptive agents. We controlled for influences of hormonal change related to menstrual 20 cycle by including only women who used single-phase contraceptives (with 0.15 mg 21 levonorgestrel and 0.03 mg ethinylestradiol), and tested them during the 3-week period they 22 were using these contraceptives, but not during menstruation 1 . We exclusively recruited 23 women because the parameters (quantity and time course) for inducing neurophysiological 24 effects after a single sublingual administration of 0.5mg of testosterone are known in women 25 but not in men 2,3 . These parameters, that is, 0.5 mg testosterone with and measurements 4 26 hours after administration were established using vaginal pulse amplitude (VPA), a uniquely 27 non-habitual, centrally driven response evoked by erotic material 2 . To date, no method is 28 available to assess the time course of effects of testosterone in human males. Crucially, 29 behavioral effects after a 4-h delay has been successfully established in more than 25 studies, 30 addressing sexual, social, and emotional behaviors in young women (e.g. [4][5][6][7][8][9][10] ). 31 32 Zero-sum two-person poker game 33
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Participants played the game in a cubicle on a computer and were connected with the other 54 participants' using Z-tree 3.0 software 12 . 55
56

Social dominance 57
We used the combined subscales Reward responsiveness (BASR) and Drive (BASD) of the 58
Behavioral Activation Scale (BAS), which is a validated measure of social dominance. These 59 BAS scales in measuring approach motivation and reward sensitivity 13 , tap into dominance as 60 established previously using social-affective reaction time and infrared eye-tracking 61 paradigms [14] [15] [16] [17] . Neuroeconomic research has shown that BASD and BASR predicts higher 62 offers in the Ultimatum Game 18 , which are argued to point at increased concerns for social 63 status 19 . 64 Nederland BV) was used as a tracer following chromatographic verification of its purity. The 86 lower limit of detection was 10 pmol/L, and interassay variation was 16.1, 11.5, and 5.1% at 87 21, 100, and 230 pmol/L, respectively (n = 4, 5, 5). Samples of one subject were not available, 88 and sample of a second subject was contaminated on the basis of abnormal range. Main 89 analyses concern samples of 18 subjects in placebo condition. 90
91
Statistical analyses 92
For bluffing behaviour, we restrict our analysis to initial bets for hands < ⅔ according to 93 theoretical framework of the game 11 . We examined the impact of testosterone [binary 94
indicator for testosterone (1) or placebo (0)], hand (continuous variable ranging from 0 to 1), 95 and interaction term (testosterone x (hand -mean hand) on the probability of betting "high" 96 (= 1, betting "low" = 0) as the dependent variable.. To qualify the testosterone x hand 97 interaction observed for bluffing behaviour, the bluffing range was split into three equal-sized 98 parts (0 -.22; .23 -.44; .45 -.66) on the basis of a priori hypotheses concerning cold bluffing. 99
Crucially however, we objectively defined the hand ranges wherein the overall (i.e. placebo 100 4 and testosterone conditions combined) relationship between betting behaviour and hand 101 changed significantly. We applied a moving average to the logistic betting distribution (first 102 bets (B) only with betting "high" B=1 and betting "low" B=0), which was subsequently 103 transformed to its linear equivalent by applying a natural logarithm to the odds-ratio of high 104 bets (lnOR with lnOR(B)=ln(B/ (1-B)) ). The moving average was also applied to the poker-105 hand data and its window was set to include all observations between hand(H)=H and 106 hand(H)=H+0.05, which ensured elimination of the occurrence of undefined lnOR values (i.e. 107 lnOR(0)=ln(0/1) and lnOR(1)=ln(1/0)). Next, we used a Bai-Perron multiple break point test For the calling behaviours, we examined the impact of testosterone (1) or placebo (0)], hand 128 (continuous variable ranging from 0 to 1), and an interaction term (testosterone x (hand -129 mean hand) on the probability of betting "calling" ( = 1) as the dependent variable (0 130 = "folding"). We analysed individual differences (i.e. salivary testosterone levels, 2D: 4D 131 digit ratio and BAS-dominance scores) using random effects logistic models. In these models 132 "betting" was the dependent variable (0: betting low; 1: betting high) and hand, BAS scores 133
and hand x BAS scores as well as salivary T levels and hand x salivary T interaction terms 134 were predictor variables. On the basis of our previous studies in which we report effects of 135 testosterone on behaviour modulated by the right hand's second-to-fourth-digit ratio, a proxy 136 of prenatal hormonal priming 8,24,25 , we performed a full random effects logistic model with: 137 dependent variable (0: betting low; 1: betting high) and predictors: hand, testosterone/placebo 138 administration (1 or 0), digit ratio, two-way interaction terms (testosterone x (hand -mean 139 hand); digit ratio x hand; digit ratio x testosterone administration) and a three-way interaction 140 term (hand x T administration x digit ratio) as predictor variables. 141 142
Beliefs about the effects of testosterone on poker play 143
Most of the participants reported that they believed that testosterone administration: would: 1) 144
Increase a desire to gamble (90% reported that testosterone would increase a desire to gamble; 145 10% had no idea); 2) Increase a willingness to take risks (95% increase; 5% no idea); 3) 146
Increase bluffing 65% (35% no idea); 4) Increase calling (60% increase (40% no idea). 147
Importantly, there was thus not one participant who believed that testosterone administration 148 would decrease a desire to gamble, willingness to take risks, bluffing or calling. 149 6 150 151
Beliefs concerning condition 152
On the final day of the experiment participants were asked on what day they believed to have 153 received testosterone, that is, 1 st or 2 nd day or whether they had no idea. 10 guessed correctly 154 and 10 guessed wrong or had no idea. To test whether participants' correct belief of having 155 received testosterone in any way interacted with our effects of testosterone on bluffing and 156 calling, we ran the bluffing and calling analyses again with the binary "belief" indicator 157 denoting whether the participant guessed correctly (1) or not (0) as covariate in random 158 effects analyses. The reported bluffing and calling effects remained significant, and the 159 covariate "belief" did not predict bluffing (p = .225) nor calling behavior (p = .216). 160
161
Beliefs about the effects of testosterone on gambling, bluffing and calling 162
The majority of participants reported that they believed that testosterone administration 163 would: 1) increase a desire to gamble (90% reported that testosterone would increase a desire 164 to gamble; 10% had no idea); 2) increase a willingness to take risks (95% increase; 5% no 165 idea); 3) increase bluffing (65% more often place higher bets for hands < .50; 35% no idea); 166 and 4) increase calling (60% increase; 40% no idea). Specifically, no participants reported 167 that they expected testosterone administration to: 1) decrease a desire to gamble, 2) decrease a 168 willingness to take risks, 3) decrease bluffing, or 4) decrease calling. 169 170
